V011-0276 Screening compound: N-{trans-4-[(4-fluorobenzoyl)(3-methylbenzyl)amino]cyclohexyl}-1-(phenylacetyl)-4-piperidinecarboxamide

V011-0276 Screening compound: N-{trans-4-[(4-fluorobenzoyl)(3-methylbenzyl)amino]cyclohexyl}-1-(phenylacetyl)-4-piperidinecarboxamide
V011-0276 Screening compound: N-{trans-4-[(4-fluorobenzoyl)(3-methylbenzyl)amino]cyclohexyl}-1-(phenylacetyl)-4-piperidinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-0276
N-{trans-4-[(4-fluorobenzoyl)(3-methylbenzyl)amino]cyclohexyl}-1-(phenylacetyl)-4-piperidinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-0276

Molecular Formula

C35H40FN3O3 (C35 H40 FN3 O3)

Compound Name

N-{trans-4-[(4-fluorobenzoyl)(3-methylbenzyl)amino]cyclohexyl}-1-(phenylacetyl)-4-piperidinecarboxamide

IUPAC name

1-(2-phenylacetyl)-N-[(1r4r)-4-{N-[(3-methylphenyl)methyl]4-fluorobenzamido}cyclohexyl]piperidine-4-carboxamide

SMILES

Cc1cccc(CN([C@H](CC2)CC[C@@H]2NC(C(CC2)CCN2C(Cc2ccccc2)=O)=O)C(c(cc2)ccc2F)=O)c1

InChI

InChI=1S/C35H40FN3O3/c1-25-6-5-9-27(22-25)24-39(35(42)29-10-12-30(36)13-11-29)32-16-14-31(15-17-32)37-34(41)28-18-20-38(21-19-28)33(40)23-26-7-3-2-4-8-26/h2-13,22,28,31-32H,14-21,23-24H2,1H3,(H,37,41)

InChI Key

GLHYTJJNCXKAIB-UHFFFAOYSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

569.72

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.087

Distribution Coefficient, logD

5.087

Water Solubility, LogSw

-5.01

Polar Surface Area

55.490

Acid Dissociation Constant (pKa)

15.04

Base Dissociation Constant (pKb)

5.98

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

V011-0276 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V011-0276 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-0276?
Check Price and Availability of V011-0276, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-0276 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-0276
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-0276
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-0276 available by request